The present invention is directed to systems for applying a silicone based topical skin adhesive, from a dual barrel syringe containing a two-part rapidly cross-linkable silicone composition for application onto tissue, the dual barrel syringe terminates in a static mixer configured for mixing and expressing the silicone composition, the static mixer having a medicant deposited on an inner surface thereof, the medicant configured for being released and picked up from the inner surface by the cross-linkable silicone composition during expression of the composition from the dual barrel syringe.
A61B 17/00 - Surgical instruments, devices or methods
C08L 83/00 - Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon onlyCompositions of derivatives of such polymers
A pressure distribution implant for use in sternal closure includes an elongated body having first and second ends, a longitudinal axis, and top and bottom surfaces that extend along the longitudinal axis. A plurality of spaced anchors project from the top surface of the elongated body, each including a segment of an elongated channel extending therethrough that is aligned with the longitudinal axis of the elongated body. Each spaced anchor has an opening that is in communication with the segment of the elongated channel associated therewith. The spaced anchors define gaps therebetween that overlie the top surface of the elongated body. The elongated body is flexible and is more flexible at the locations of the gaps and less flexible at the locations of the spaced anchors. An elongated tissue closure device is secured to the anchors for applying pressure for sternal closure.
A surgical ligation clip includes a first arm extending from a proximal end to a first distal end. The first arm includes a distal hook at the first distal end. The surgical ligation clip also includes a second arm extending from the proximal end to a second distal end. The second arm is pivotable relative to the first arm about a proximal hinge to clamp tissue between the first and second arms. The second arm includes a proximal portion and a distal portion. The distal portion is pivotable relative to the proximal portion about a distal hinge.
The invention relates to hemostatic compositions comprising ellagic acid-metal complex and uses thereof for activating the intrinsic pathway of blood coagulation. In particular, disclosed are hemostatic compositions comprised of ellagic acid complexed with nickel ions, the complex being dispersed or embedded within an absorbable polymeric matrix such as gelatin. Further disclosed are method for making the hemostatic compositions.
HSHS) that indicates a probability of a micro-organism expressing growth once exposed to a unit of sterilant; determine, based, at least in part, on the hypothesized sterilant resistance, an estimated number of samples that include a micro-organism expressing growth once exposed to the unit of sterilant; determine an observed number of samples that include a micro-organism expressing growth subsequent to exposure to the unit of sterilant; iteratively determine, based on one or more iterations, at least one first correction based on the observed number and the estimated number, and apply convergence criteria to determine whether to perform a next iteration; and determine the application condition of the sterilant, based on the first correction. Other aspects are also described and claimed.
G16H 40/00 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices
6.
METHODS FOR TREATING LEAKAGE FROM A GASTROINTESTINAL SITE
Disclosed herein are flowable biocompatible sealant compositions in the form of a biodegradable cross-linked gel, comprised of an insoluble agent for preventing infection, and an agent for preventing ischemia, wherein the agent for preventing ischemia is embedded in polymeric microparticles. The composition is characterized in that it releases at least part of said agents in a sustained manner. Uses of the compositions in methods for treating a leakage from a gastrointestinal site are further disclosed.
The present invention is directed to a sealant patch for use on or over sensitive tissue, comprising: a flat, flexible, bioresorbable substrate coated by a moisture-activated adhesive on one side thereof, wherein said adhesive is at least partially inactivated in a first portion of said patch, but remains active in peripheral areas surrounding the first portion. The adherence of the first portion to the tissue is weaker versus adherence in the peripheral areas. The adhesive in the first portion is fully or partially inactivated or pre-reacted prior to application of the sealant patch to the tissue.
A61F 15/00 - Auxiliary appliances for wound dressingsDispensing containers for dressings or bandages
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
The present invention is directed to methods for processing absorbable, slow-to-crystallize poly(p-dioxanone) ground resin and its fines utilizing a twin-screw extruder apparatus to produce uniform pellets. Advantageously, the ground resin materials resulting from solid-state polymerization do not undergo processing, such as sieving, to remove fines from the feedstock for an extrusion and pelletizing system that has been configured with an inverted temperature profile along the extrusion barrel. The resulting PDS pellets have improved resin uniformity and greater polymer yield for improved operational efficiencies and production of extruded filaments.
The present invention is directed to hemostatic and/or tissue adhesive formulations comprising crosslinked polysaccharide particles that have been oxidized to generate aldehyde- and carboxylic functional moieties therein, and wherein said formulations further contain a buffer that maintains a slightly alkaline environment. These formulations can be applied onto tissue in the form of a powder, paste or patch to effect hemostasis or sealing.
Disclosed herein are powdered compositions comprised of fibrinogen, thrombin, glycerol-water solution, and optionally oxidized cellulose (OC), wherein the glycerol is present at a concentration ranging from about 0.7% to about 6%, by weight; and wherein the OC is present at a concentration below about 9%, by weight, or is absent. Methods of making the compositions, and uses of the compositions in methods for treating a bleeding tissue, and for sealing leaks in tissues are further disclosed.
Disclosed is a sealant, and techniques for making and using the sealant. The sealant may include three components that, when combined, produce the sealant: an electrophilic component, a nucleophilic component, and a doping component. The electrophilic component may include a first electrophilic material having a first functionality of a first reactive group. The nucleophilic component may include a first nucleophilic material having a second functionality of a second reactive group. The doping component may include a second electrophilic material having a third functionality of the first reactive group greater than the first functionality and/or a second nucleophilic material having a fourth functionality of the second reactive group greater than the second functionality. The doping component may be present in an amount sufficient to provide a 2-20% molar contribution of the first reactive group and/or the second reactive group in the sealant.
Methods and systems for using a biocompatible and flexible hemostatic sheet comprising a fibrous carrier structure, and reactive electrophilic groups capable of reacting with amine groups in tissue and blood, the hemostatic sheet delivered through a trocar for restoring hemostasis to a tissue at a bleeding site of an organ during minimally invasive treatment of hemorrhage.
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
A61L 15/42 - Use of materials characterised by their function or physical properties
13.
SYSTEM AND METHODS FOR USING TISSUE-ADHESIVE POROUS HEMOSTATIC PRODUCTS WITH SEVERE SURFACE AND CAVITY BLEEDING
Methods and systems for using a biocompatible and flexible hemostatic sheet comprising a fibrous carrier structure, and reactive electrophilic groups capable of reacting with amine groups in tissue and blood, the hemostatic sheet delivered to the tissue at the bleeding site of an organ to restore hemostasis during an open surgery procedure.
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
A61L 15/42 - Use of materials characterised by their function or physical properties
Provided herein are methods for preparation of fibrinogen by purifying fibrinogen from a plasma fraction being depleted of prothrombin. The plasma fraction depleted of prothrombin is obtained, for example, by adding an anticoagulant to a source of blood; separating plasma from the source of blood, and extracting the prothrombin from the plasma, thereby obtaining a prothrombin depleted plasma fraction and a plasma fraction comprised of prothrombin.
The present invention is directed to compressed hemostatic tablets or forms comprising a fibrous non-woven oxidized cellulose (OC or ORC) multilayer material compressed into a form stable tablet, further comprising calcium salt, with the tablets rapidly expandable on contact with blood or blood plasma. The compressed forms may further comprise a multi-arm PEG-SG and are dimensionally, preferably with regard to length and width, stable for at least 48 hours after compression. In some embodiments, the compressed forms will expand upon contact with blood from 1.5 to 5 times of tablet length in 5 seconds; from 2 to 6 times of tablet length in 20 seconds; and from 3 to 6 times of tablet length in 5 minutes. The compressed forms are effective in hemostasis in heparinized blood.
Provided herein are hydrogel-hydrocolloid sealant compositions for use as soft-tissue sealants. The compositions can include a cross-linkable electrophilic component; a cross-linkable nucleophilic component; a swellable filler material including gelatin; and, a buffer having a pH in the range of about 9.0 to about 10.0. The compositions can have a first fluid state and a second crosslinked state, and in the crosslinked state, the electrophilic and nucleophilic components can crosslink to form a crosslinked hydrogel network where the swellable filler material including gelatin is disposed within the crosslinked network. Also provided are systems and methods of manufacturing the sealant compositions as well as methods of repairing soft tissue defects including applying the sealant compositions disclosed herein.
The disclosure encompasses systems, compositions, and methods for use in vivo, including for reinforcement of soft tissue in an individual. The systems, compositions, and methods may utilize three-dimensionally printed scaffolds comprising at least a polymer scaffold and an extracellular matrix component(s), including comprised on the scaffold. The polymer scaffold may comprise particular unit cell structures of a specific design and patterns of alternating configurations of the unit cell structures.
A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
The invention relates to biodegradable bilayer sealants for tissue closure. The sealants of the invention are composed of two layers with different compliances. The layer in immediate contact with the tissue has high compliance. The second layer located immediately above the first sealant layer has low compliance, i.e. the sealant is much stiffer. The burst pressure of the bilayer sealants is enhanced relative to either a single layer elastic sealant or a single layer stiff sealant. The improved sealant compositions herein provide a water-tight seal, can access hard to reach tears, be applied in a dry or wet environment, are low-swelling, and can repair a range of incision or tear sizes. The bilayer sealants are particularly useful for sutureless dural closure or as adjuncts to sutured dural closure. Also provided herein are methods of preparing and using the biodegradable sealant compositions.
The invention relates to a rapid setting liquid lung sealant that forms a highly adherent and elastic hydrogel. Provided are lung sealants comprising two high molecular weight (20 kDa) multi-arm PEG compositions wherein the first PEG composition includes an alkaline buffer and the second PEG composition includes a mildly acidic buffer for optimized set up time and extended working time. In some embodiments, the PEGs further comprise a radioprotectant such as tocopherol. In some embodiments, a colorant is added to one or both PEGs of the lung sealant to improve visualization of the lung sealant against human lung tissue.
Provided herein are compositions, systems and surgical methods for treating expandable soft tissue utilizing a reactive liquid hydrogel sealant mixture including a cross-linkable electrophilic compound, a nucleophilic compound, and an amphiphilic poly(akyl)ene glycol block polymer in an amount of 20% (w/v) or less of the sealant composition. The composition can optionally include a viscosifier, in an amount of 0.1% to 1.0% (w/v) of the sealant composition.
A device comprising may include a processor. The processor may be configured to receive data indicative of air exchange between a surgical ventilator and a patient. The processor may be configured to receive data indicative of air leaving the patient via a chest tube. With regard to this data, the processor may be configured to sample one or more sensors at a rate to capture an identifiable signal associated with prolonged-air-leak-occurrence for a population. And this signal may be predictive of the likelihood of a prolonged air leak developing in the patient. For example, a machine learning model may be trained using the data indicative of ventilator-patient air exchange, chest tube air loss, and prolonged-air-leak-occurrence for a population.
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
The present invention is directed to coated medical devices, such as implantable and coatable devices, such as sutures, with expanded antibacterial properties, handling, knot slide and in-situ performance and processes for their manufacture and use.
A device may include a sensor and a processor. The sensor may measure air leaving a patient via a chest tube. The processor may be configured to sample data from the sensor. For example, the processor may be configured to sample data from the sensor at a rate suitable to capture a signal associated with prolonged-air-leak-occurrence for a population. For example, the rate may be suitable to capture variations in the measure air within a breath cycle. For example, rate may be suitable to capture a number and magnitude of peaks in the signal. Based on the signal, the processor may output information indicative of prolonged-air-leak-likelihood for the patient.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
A device may include a processor. The processor may be configured to receive data during a surgery. The processor may receive data representative of a patient's intraoperative air exchange. The data may represent air exchange for a patient's breath cycle. For example, data may include any of ventilator inlet flow rate, ventilator inlet pressure, ventilator output pressure, chest tube flow rate, or chest tube pressure. The processor may also receive data representative of a surgical parameter other than one related to air exchange. For example, this data may include any of patient medical record data, intraoperative reporting data, surgical procedure data, or the like. The processor may be configured to receive an updated machine learning model from a cloud resource. And the processor may output, during the surgery, information indicative of prolonged-air-leak-likelihood based on data.
G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
A61B 5/08 - Measuring devices for evaluating the respiratory organs
A61M 16/10 - Preparation of respiratory gases or vapours
25.
VARIABLE LENGTH TELESCOPING APPLICATION TIPS FOR FLOWABLE HEMOSTATS AND SEALANTS APPLICATION
The present invention is directed to a variable length applicator system for delivery of at least one medically useful liquid, comprising an elongated, telescopically extendable, variable length cannula having a liquid pump containing said liquid connected to said cannula at a proximal end, and a spray nozzle mounted on said cannula at a distal end; a coiled and extendable tubular conduit connected to and in fluid communication with, both said liquid pump and said spray nozzle; wherein an axial extension of said cannula is configured to cause a matching axial extension of said coiled tubular conduit.
A mixing and spraying assembly for a tissue sealant includes a mixing assembly, a spray tip assembly, and a malleable section having a proximal end connected with the mixing assembly and a distal end connected with the spray tip assembly for enabling the spray tip assembly to be angulated relative to the mixing assembly. The malleable section includes a flexible shaft having a length, a malleable wire conduit that extends along the length of the flexible shaft, and a malleable wire disposed in the malleable wire conduit. The malleable wire is longer than the flexible shaft and has a proximal end that is connected to the mixing assembly and a distal end that is connected to the spray tip assembly. First and second fluids are mixed within the mixing assembly to form a tissue sealant that is delivered through the malleable section for being expressed from the spray tip assembly.
A61B 17/00 - Surgical instruments, devices or methods
27.
SYSTEMS, DEVICES AND METHODS FOR RECONSTITUTING THERAPEUTIC POWDERS, MIXING PRECURSOR SOLUTIONS, AND EXPRESSING SEALANTS FOR CONTROLLING BLEEDING AND SEALING FLUID AND AIR LEAKS
A sealant delivery system includes a syringe assembly having side-by-side syringes and a vial assembly having side-by-side vials. A first vial is aligned with a distal end of a first syringe and has a vial opening at the proximal end thereof that is closed by a first sealing membrane. A second vial is aligned with a distal end of a second syringe and has a second vial opening at the proximal end thereof that is closed by a second sealing membrane. The vial assembly includes a first piercing element moveable between a retracted position and an extended position for piercing the first sealing membrane to provide fluid communication between the first fluid chamber and the first vial, and a second piercing element moveable between a retracted position and an extended position for piercing the second sealing membrane to provide fluid communication between the second fluid chamber and the second vial.
An assembly includes an insertion device and a suture delivery device. The insertion device includes a longitudinal guide member extending from a proximal end to a distal tip. The tip includes an abutting structure movable between insertion and open positions. The structure is sized and shaped to contact tissue surrounding the tissue opening into which the insertion device has been inserted to maintain a desired position of the insertion device within the opening. The delivery device includes a body and a tube. The tube extends along a curved path configured so that, as the tube is rotated about the member, the tube penetrates tissue surrounding the opening into which the member has been inserted. A distal extension of the tube is configured so that, when the tube has been advanced distally to a distal-most position on the member, a distal end of the tube is proximal of the structure.
Various embodiments of the present invention are directed towards a single barrier folder to carry a suture and a needle therein. The single barrier folder comprises a plurality of openings configured to allow placement of a suture and form a suture winding and a first flap comprising a needle parking mechanism. The needle parking mechanism comprises a first portion, a notch, and a cutout. The cutout and the notch are configured to hold the needle and the first portion is foldable and configured to fold in locking engagement with the notch. The single barrier folder also comprises a second flap and a third flap on opposite sides of the plurality of openings and a slit configured to receive an end portion of a fourth flap to lock the single barrier folder. The present invention also provides method of placing and folding the flaps to pack needle and suture inside the single barrier folder.
A sealant delivery device includes a housing, a matrix container connected with a distal end of the housing and being moveable between closed and opened positions, and a matrix, such as a hemostatic substrate, disposed within the matrix container. The sealant delivery device includes a sealant dispensing system in fluid communication with the matrix container that is configured for dispensing a sealant onto the matrix disposed within the matrix container. An actuator is coupled with the sealant dispensing system and the matrix container. The actuator is engageable for opening the matrix container for exposing the matrix and expressing the sealant onto the matrix. A component of the matrix container may be used to press the matrix and sealant expressed onto the matrix against target tissue to control bleeding of the target tissue.
A61B 50/30 - Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments
A61M 35/00 - Devices for applying media, e.g. remedies, on the human body
A61B 17/00 - Surgical instruments, devices or methods
A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
A61F 2/00 - Filters implantable into blood vesselsProstheses, i.e. artificial substitutes or replacements for parts of the bodyAppliances for connecting them with the bodyDevices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
Disclosed is a powdered composition comprised of: (i) thrombin, (ii) total protein in an amount of less than 75%, by weight, (iii) albumin in an amount of more than 5% by weight and iv) a non-acidic amino acid, the composition being substantially free of carbohydrates. A Method for preparing thrombin powders is also disclosed herein.
The invention relates to compositions comprised of albumin and clottable proteins including fibrinogen and to use thereof e.g., for treating bleeding. In particular, the compositions are comprised of albumin and one or more clottable proteins, wherein the albumin and the one or more clottable proteins are present at a total concentration of at least 90% by total protein weight, wherein the clottable protein fibronectin is present at an amount of less than about 0.5% by total protein weight or is absent, and wherein the weight ratio of the albumin to the clottable protein fibrinogen is at least 1:15, respectively.
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
A61L 15/32 - Proteins, polypeptidesDegradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
A61L 15/42 - Use of materials characterised by their function or physical properties
A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
A61L 24/04 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials
The present invention provides a tissue sealing plug comprising a substrate comprising foamed gelatin impregnated with polyethylene glycol that is liquid at room temperature, wherein the weight ratio of polyethylene glycol to foamed gelatin in the substrate is about 4:1 to about 6.8:1 and the substrate is substantially free of air, along with methods of using the plug for closing tissue punctures in the lung.
The present invention is directed to an implantable medical device, comprising: a device body, with at least a portion of said body coated by a sensing coating that comprises an echogenic material or a radiopaque material, or combinations thereof, said sensing coating configured to dissolve or swell in presence of at least one infection biomarker; wherein a portion of said sensing coating is covered by a protective film, forming a protected portion, said protected portion configured not to dissolve or swell in presence of said biomarker and methods of detecting presence of biomarkers in the vicinity of an implanted medical device.
A61L 17/14 - Post-treatment to improve physical properties
A61B 17/00 - Surgical instruments, devices or methods
A61B 17/06 - NeedlesHolders or packages for needles or suture materials
A61B 90/30 - Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
35.
SYSTEMS, DEVICES AND METHODS OF USING HYDRAULIC FORCES FOR DELIVERING FLOWABLE, THERAPEUTIC COMPOSITIONS TO SURGICAL SITES
A system for delivering a flowable, therapeutic composition, such as a flowable hemostat, biologics, or a medicine paste, includes a cannula having a proximal end with a proximal opening, a distal end with a distal opening, and an elongated lumen extending from the proximal end to the distal end. The flowable, therapeutic composition fills the elongated lumen of the cannula, and a piston is disposed within the elongated lumen for sealing the proximal end of the cannula. An end cap is secured to the distal end of the cannula. A pump assembly includes a fluid and is coupled with the proximal end of the cannula. After the end cap, is removed, the pump assembly is operable to pump the fluid for directing the fluid to flow through the proximal opening of the cannula to force the piston to slide toward the distal end of the cannula to express the flowable, therapeutic composition from the distal end of the cannula.
A61B 17/00 - Surgical instruments, devices or methods
A61B 17/12 - Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
The present invention provides a kit for preparing a composition for sealing a lung tract, comprising: (a) a first component comprising: (i) a fibrinogen solution, and (ii) prewet gelatin particles in an aqueous solution; and (b) a second component comprising: (i) a thrombin solution, and (ii) a dry gelatin powder; wherein the first and second components are stored separately and configured for mixing together to form a composition that is flowable and cross-linkable. The composition may be used to seal tissue tracts such as lung tissue tracts.
A combined powder and liquid delivery device includes a housing having a powder chamber and a liquid chamber. The device includes an applicator tip having a powder delivery channel extending between a proximal end and a distal end of the applicator tip that is in fluid communication with the powder chamber, and a liquid delivery channel that extends from the proximal to the distal end of the applicator tip that is in fluid communication with the liquid chamber. The delivery device includes a powder inlet port in fluid communication with the powder chamber, and a liquid inlet port in fluid communication with the liquid chamber. A powder delivery system is in fluid communication with the powder inlet port, the powder chamber, and the powder delivery channel. A liquid delivery system is in fluid communication with the liquid inlet port, the liquid chamber, and the liquid delivery channel.
The present invention relates to a suturing system, comprising: an elongated flexible suture having a connecting end attached to a needle and an opposing free end, said suture co-packaged with a pierceable container containing a medicant solution. The invention further relates to a suturing system, comprising: an elongated flexible suture having a connecting end attached to a needle and an opposing free end, said suture co-packaged with a wicking medicant transfer sponge and a frangible container containing a liquid. In some embodiments, the invention relates to a suturing system, comprising: an elongated flexible suture having a connecting end attached to a needle and an opposing free end, said suture co-packaged with a medicant transfer sponge, said system further comprising a medicant dispenser container with a liquid.
A method of making a catheter includes obtaining a hollow tube having a proximal section, a distal section, an elongated conduit, and one or more fluid openings formed in the distal section of the hollow tube that are in fluid communication with the elongated lumen. The method includes inserting a mandrel within the elongated lumen, positioning a first visible marker over an outer surface of the hollow tube at a junction of the proximal and distal sections of the hollow tube, and placing a sacrificial material over the first visible marker to completely cover the first visible marker. Heat is applied for shrinking the sacrificial material, which, in turn, compresses the first visible marker against the outer surface of the hollow tube, and for least partially melting the first visible marker for fusing the first visible marker to the outer surface of the hollow tube.
A catheter for delivering fluids includes a hollow tube having a proximal section, a distal section, and an elongated lumen that extends through the proximal and distal sections of the hollow tube. One or more fluid openings are formed in the distal section of the hollow tube, which are in fluid communication with the elongated lumen of the hollow tube. A visible marker collar is secured to an outer surface of the hollow tube and is located at a junction of the proximal and distal sections of the hollow tube. A visible marker filament is disposed within the elongated lumen of the hollow tube and extends between the junction of the proximal and distal sections of the hollow tube and a distal end of the hollow tube. The visible markers are used to identify a soaker region of the catheter used to infuse fluids or drain fluids from a patient.
A system for creating separation between biological surfaces may comprise a hollow body configured for delivery of a fluid to a target location, a fluid supply in fluid-communication with the hollow body, a control element configured to control the delivery of a fluid through the hollow body, at least one first sensor configured to measure at least one parameter of the fluid flowing through the hollow body, at least one second sensor configured to measure at least one parameter of an environment of the hollow body, a feedback control module configured to receive information from one or more of the at least one first sensor or the at least one of the second sensor to control at least one operational function of the system.
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 34/20 - Surgical navigation systemsDevices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
A61B 17/00 - Surgical instruments, devices or methods
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
42.
METHOD AND DEVICE FOR INTRMYOCARDIAL INFUSION OF CONDUCTIVE NANOPARTICLES
An injection catheter (300) for the improvement of intramyocardial conduction delay, the catheter comprising: a catheter body; a tip section (312) comprising a needle passage; a needle control handle (308); an injection needle (314) which is longitudinally slidable so that the distal end of the injection needle extends beyond the distal end of the tip section upon suitable manipulation of the needle control handle; and a needle stop disposed on a portion of the injection needle, wherein the needle stop has a distal end that is sized to prevent passage of the portion of the injection needle on which the needle stop is mounted from passing into the distal region of the needle passage thereby limiting a distance that the injection needle is capable of extending beyond the distal end of the tip section.
The present disclosure relates to systems and methods to magnetically influence the position, orientation, movement, and/or activation of a medical device within an operating region within the body using a magnetic guidance system introduced into a target location of a body. More specifically, the present disclosure relates to magnetic navigation systems for applying a magnetic field to an operating region within the body, the system comprising a first magnet assembly configured for introduction into a target location of a body and a second magnet assembly disposed opposite the first magnet assembly, wherein the first and second magnet assemblies are configured for applying a magnetic field to an operating region between the magnet assemblies.
A device is configured for use in negative pressure wound therapy (NPWT). The device includes a tube having a tube proximal end and a tube distal end and A coil having a plurality of windings extending from a coil proximal end to a coil distal end. The coil distal end is coupled to the tube proximal end in a manner that enables application of a negative pressure from within the coil through the coil to tissue surrounding the coil. The coil comprises a space between adjacent ones of the plurality of windings, the space having a predetermined dimension.
A61M 1/00 - Suction or pumping devices for medical purposesDevices for carrying-off, for treatment of, or for carrying-over, body-liquidsDrainage systems
45.
SUTURES WITH EXTERNAL FILAMENT CONTAINING A MEDICANT
The present invention is directed to suturing systems having a needle, an elongated flexible suture having a connecting end attached to a said needle and an opposing free end and at least one elongated external beneficial filament that is attached to said needle or attached to said suture at the connecting end. The beneficial filament has a smaller cross-sectional area and lower mechanical strength than the suture and contains a medicant.
Disclosed herein are two-component flowable compositions comprised of: (i) a powder of: oxidized cellulose, fibrinogen and thrombin, with the weight ratio of the oxidized cellulose to the fibrinogen ranging from about 1: 5 to about 2: 1, respectively; and (ii) a dispersant comprised of glycerol and an aqueous solution, the composition being in the form of a pasty suspension at a room temperature. Also disclosed are uses of the compositions for treating a bleeding tissue, and methods for making the compositions.
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
A61B 17/12 - Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
48.
SYSTEMS, DEVICES AND METHODS FOR DISPENSING FLOWABLE HEMOSTATS THAT INCORPORATE SAFETY MECHANISMS FOR PREVENTING AIR EMBOLISMS
A dispensing system includes a hollow tube having an outer wall with an air vent formed in the outer wall. A valve including a flexible flap is disposed inside the tube. The flexible flap, normally biased into a retracted position, is moveable between an extended position for sealing the air vent and the retracted position for unsealing the air vent. A syringe connector interconnects a syringe with the proximal end of the hollow tube and defines a fluid flow path. A flowable viscous fluid is disposed within the syringe. When a syringe plunger is depressed, the flowable viscous fluid is expelled from the syringe and forced through the fluid flow path and into the proximal end of the hollow tube. When the flowable viscous fluid engages the flexible flap, the flexible flap is forced to move into a position that seals the air vent.
The present invention is directed to devices and systems for delivering a flowable medicant (100) into a surgical site from a container (10) configured to hold the flowable medicant. The container having a tubular elongate member (14) sized and configured to be inserted into a body (300) though a tubular instrument (120a), such as a surgical access device. The tubular elongate member is operatively connected to the container and has a proximal end and a distal end. The distal end terminates as an exit port that is configured to discharge the flowable medicant at the surgical site, and a flow control device (22) operatively connected to the container or the tubular elongate member for metering the flow of medicant from the container, through the tubular elongate member to the exit port.
A61B 17/00 - Surgical instruments, devices or methods
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
50.
SYSTEMS AND DEVICES FOR DISPENSING BIOCOMPATIBLE REACTIVE FORMULATIONS AND CONTROLLING CROSS-LINKING OF THE REACTIVE COMPONENTS OF THE BIOCOMPATIBLE REACTIVE FORMULATIONS
A system for dispensing a biocompatible reactive formulation includes a first chamber containing a first fluid having a first reactive component, a second chamber containing a second fluid having a second reactive component, and a third chamber containing a third fluid. A spray tip assembly is configured for spraying a final mixture of the first, second and third fluids. The spray tip assembly has a spray tip housing, a mixing element disposed within the spray tip housing, a mixing chamber located between the mixing element and an inner surface of the spray tip housing. The mixing element has a proximal end adjacent the proximal end of the spray tip housing and a distal end adjacent the distal end of the spray tip housing, a third fluid inlet opening at the proximal end of the mixing element, and one or more third fluid exit openings formed in the outer surface of the mixing element that are in fluid communication with the third fluid inlet opening and that extend laterally to the outer surface of the mixing element for being in fluid communication with the mixing chamber. A fluid connector is secured to the proximal end of the spray tip housing and opposes the proximal end of the mixing element. The fluid connector has first and second fluid channels in fluid communication with the mixing chamber, and a third fluid channel in fluid communication with the third fluid inlet opening of the mixing element. A pump assembly is coupled with the first, second and third chambers for simultaneously forcing the first, second and third fluids to flow through the first, second and third fluid channels of the fluid connector and into the proximal end of the spray tip housing.
A61M 11/00 - Sprayers or atomisers specially adapted for therapeutic purposes
B05C 17/005 - Hand tools or apparatus using hand-held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material through an outlet orifice by pressure
B05B 7/04 - Spray pistolsApparatus for discharge with arrangements for mixing liquids or other fluent materials before discharge
B05B 11/00 - Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
B05B 11/02 - Membranes or pistons acting on the contents inside the container, e.g. follower pistons
B01F 25/313 - Injector mixers in conduits or tubes through which the main component flows wherein additional components are introduced in the centre of the conduit
B01F 25/434 - Mixing tubes comprising cylindrical or conical inserts provided with grooves or protrusions
B01F 25/441 - Mixers in which the components are pressed through slits characterised by the configuration of the surfaces forming the slits
B01F 33/501 - Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
B05B 1/34 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl
B01F 101/22 - Mixing of ingredients for pharmaceutical or medical compositions
B01F 101/00 - Mixing characterised by the nature of the mixed materials or by the application field
51.
TWO COMPONENT SEALING SYSTEMS INCLUDING SYNTHETIC MATRICES AND BIOSYNTHETIC ADHESIVES
The present invention is directed to a hemostatic patch comprising a porous substrate and at least a pair of co-reactive polymer reagents comprising at least one nucleophilic polyalkylene oxide based component and at least one electrophilic polyalkylene oxide-based on the porous substrate in a molar ratio of about 0.2 to about 0.9:1 of primary nucleophilic groups in excess to available electrophilic groups. The present invention is also directed to processes for the manufacture and use of such hemostatic patches.
A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
A61L 24/04 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials
52.
SUTURE NEEDLE ADAPTORS FOR DELIVERING SUTURE NEEDLES THROUGH CANNULAS WHILE SIMULTANEOUSLY VISUALIZING THE DELIVERY OF THE SUTURE NEEDLES THROUGH THE CANNULAS
A needle camera adaptor includes a tube-shaped body having a proximal end, a distal end, a longitudinal axis, and a lumen that extends along the longitudinal axis. A centrally-located lateral access opening is formed in an outer wall of the tube-shaped body. A needle securing channel is formed in the outer wall and extends between the lateral access opening and the distal end of the tube-shaped body. A curved suture needle is disposed within the needle securing channel. The needle securing channel and the curved suture needle extend along an axis that defines an oblique angle with the longitudinal axis of the needle camera adaptor. A visualization device, facing distally, is positioned within the lumen at the proximal end of the tube-shaped body. The lateral access opening, the needle securing channel, and the curved suture needle are located within a field of view of the visualization device.
A61B 17/04 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for suturing woundsHolders or packages for needles or suture materials
53.
SYSTEMS FOR LIQUID FLOODING OF LUNG TO ENHANCE ENDOBRONCHIAL ENERGY TRANSFER FOR USE IN IMAGING, DIAGNOSIS AND/OR TREATMENT
An improved system and method of endobronchial imaging of lung nodules comprises the introduction of a perfluorocarbon (PFC) liquid into pulmonary passages of the lungs, the introduction of which enables better coupling between an endobronchial ultrasonic imaging system and a target tissue site within the pulmonary passages of the lungs, the improved coupling between the ultrasonic imaging system and a target tissue site being imparted by the removal (at least in part) the air interface present between the ultrasonic imaging system and the surface of the target tissue site. Furthermore, the unique properties of perfluorocarbon liquids (for example, the properties of superb biocompatibility, high affinity for dissolving oxygen, and extremely low surface tension) further position these substances to be particularly well-suited for this application.
A61B 1/267 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor for the respiratory tract, e.g. laryngoscopes, bronchoscopes
A61B 10/02 - Instruments for taking cell samples or for biopsy
A61B 8/12 - Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
A61B 8/00 - Diagnosis using ultrasonic, sonic or infrasonic waves
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
A61B 17/00 - Surgical instruments, devices or methods
A61B 34/10 - Computer-aided planning, simulation or modelling of surgical operations
A61B 34/20 - Surgical navigation systemsDevices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
A61B 90/30 - Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
A61B 10/04 - Endoscopic instruments, e.g. catheter-type instruments
Disclosed are methods of sterile filtration of a fibrinogen solution, the method being comprised of filtering the solution with one or more filters selected from a glass fiber pre-filter and an aseptic filter made of polysulfone or a derivative thereof. Aseptic fibrinogen solutions obtained by the methods are further disclosed herein.
Disclosed are devices for detection of bleeding during surgical procedures and uses thereof. Also disclosed are methods of localizing a bleeding site during surgical procedures, and methods for evaluating an intensity of bleeding during the surgical procedures. The detection of bleeding is based, inter alia, on the presence of thrombin activity in a bleeding site.
The present invention is directed to a length adaptive surgical suture comprising a monofilament or a braid of a plurality of filaments, the suture having an original length when implanted and a second length that is different from the original length within a first twenty-four (24) hour period of time after implantation to accommodate tissue swelling. The present invention is also directed to configurations and combinations that enable length adaptive results.
A61B 17/06 - NeedlesHolders or packages for needles or suture materials
57.
METHODS AND DEVICES FOR CHANGING THE FLOW RATES OF PH MODIFYING FLUIDS FOR CONTROLLING CROSS-LINKING RATES OF REACTIVE COMPONENTS OF BIOCOMPATIBLE SEALING COMPOSITIONS
A method of making a biocompatible composition for sealing tissue includes mixing a first fluid having a first reactive component (e.g., an electrophile) and a second fluid having a second reactive component (e.g., a nucleophile) to form a mixture and expressing the mixture. During expression, a pH modifying fluid (e.g., NaOH) is added to the mixture at a rate that changes. In one embodiment, a higher ratio of the pH modifying fluid is added to the mixture during a first expressing stage and a lower ratio of said pH modifying fluid is added to the mixture during a second expressing stage. During the first expressing stage, a mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.7-1.4:1:1. During the second expressing stage, the mixing ratio of the pH modifying fluid, the first fluid and the second fluid is 0.12-0.24:1:1.
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61L 24/00 - Surgical adhesives or cementsAdhesives for colostomy devices
A61L 24/04 - Surgical adhesives or cementsAdhesives for colostomy devices containing macromolecular materials
A co-reactive liquids delivery applicator, including first and second hollow cylindrical cartridges, each including a stopper at a proximal end and a sealing septum on a distal end and the cartridges containing co-reactive liquids therein, an applicator body including two adjacent chambers configured to secure the first and second cylindrical cartridges, a manifold positioned at a distal portion of the applicator body, the manifold including a pair of hollow needles extending from a proximal portion and a tip connection positioned at a distal portion thereof, and a toggle configured to advance the manifold towards the distal end of the cartridge, wherein upon advancing the manifold each hollow needle penetrates the sealing septum and establishes fluid communication with one of the liquids of the first and second cylindrical cartridges.
Smart walking devices, assemblies, and methods of using the same. Improved partial weight bearing requirements while using a walking aid may be provided. An example smart foot assembly may include a tubular sheath with a spring assembly connected to a foot with a force sensor coupled to the spring assembly wherein during a load phase as the distal end of the foot contacts the ground, the foot moves proximally as load is increased.
Systems, computer-readable instructions, and methods for storing products are disclosed. For example, the system may include modular shelving units that include a shelf which is placeable on a rack, the shelf including a platform, the shelf having a weight sensor below the platform, the platform is configured to support N number of holders, each of the N holders configured to store products, each shelf further having N-1 optical sensors below the N-1 holders when the N-1 holders are supported by the platform and N-1 windows above the N-1 optical sensors, the N-1 optical sensors being in proximity of the N-1 holders, respectively, wherein each holder includes an opening, wherein when a holder is on the shelf, the opening is capable of being aligned with an optical sensor, the shelf further having a processing circuit coupled to the N-1 optical sensors and the weight sensor.
The present invention is directed to dry lyophilized foam plugs that are a polymeric reaction product of at least a pair of co-reactive polyethylene glycol having reactive moieties in which substantially all of reactive moieties have reacted prior to lyophilization or blend of biomaterial and a reactive polyethylene glycol or plasma derived biomaterial reaction product and wherein the plug has an overall pore void content of about 30-45%, and a microporous structure with an average pore generally between 20 and 95 µm.
A method and kit for stopping cerebrospinal fluid (CSF) leaks, comprising penetrating and passing through a dural tissue an applicator to access an interior dural space, injecting from the applicator a fibrinogen-containing solution into said dural space, applying a sealing member containing a fibrinogen polymerizing agent onto an exterior surface of the dural tissue, and forming a polymerized fibrinogen or polymerized fibrin clot by contacting the injected fibrinogen-containing solution and the fibrinogen polymerizing agent.
The present invention is directed to multi-layered wound dressings having a carrier layer, at least two sublayers, wherein each sublayer contains at least one reactive, cross-linkable component and the at least two reactive, cross-linkable components are co-reactive with the other and at least one reactive, cross-linkable has a protective leaving group and a buffering salt agent.
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
A61L 15/26 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bondsDerivatives thereof
64.
CORING AND AMPUTATION DEVICES, SYSTEMS, AND METHODS
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
A61B 10/02 - Instruments for taking cell samples or for biopsy
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
A61B 18/12 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
A method and apparatus for sealing a biologics delivery system, said applicator including two adjoining syringes, each having a barrel and an exit tube distal to the barrel, and an interchangeable delivery tip, having a delivery tip connector portion, and storage cap, each connectable to the exit tube of each barrel, and having a fixed internal O-ring for fluid-tight connection between the delivery tip and storage cap and said exit tube.
A dilation assembly comprises an expandable and contractible main body having a corrugated outer surface, a guide cannula configured to be disposed through the main body to guide a movement of the main body, and an anchor configured to fix the main body in a target position.
A surgical instrument comprises an end effector configured to core tissue, a handle operatively coupled to the end effector, wherein the handle comprises a trigger to actuate the end effector, the handle comprising a battery dock, the battery dock comprising a protruding member; and a battery unit attachable to the battery dock, wherein the battery unit is in electrical contact with at least one of the handle and the end effector when attached to the battery dock.
A61B 18/12 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
A dispensing device and cartridge for simultaneous delivery and mixing of multiple co-reactive materials, the cartridge having proximal and distal ends, and having an elongated holder body with substantially parallel longitudinal voids. Multiple syringe bodies are disposed parallel within the voids and multiple co-reactive materials are separately disposed in the syringe bodies. The dispensing device also includes a longitudinal housing which is structured and arranged to receive the cartridge and has a malleable spray or mixing tip for accessing difficult to reach locations.
The present invention is directed to medical devices having a first porous substrate layer with at least a surface coating thereon of a first co-reactive component and a second substrate layer with at least a surface coating layer of a second co-reactive component that reacts with the first co-reactive component, and a removable barrier layer positioned between the first substrate layer and second substrate layer and in contact with said first substrate layer and said second substrate layer.
The present invention relates to a hemostatic absorbable composition, comprising: a flowable plurality of separate aggregates each comprising: a plurality of absorbable carrier particles coated on a surface thereof by a plurality of smaller particles comprising an absorbable supplemental hemostasis-promoting agent. In some embodiments, the absorbable carrier particles comprise gelatin or collagen, and the supplemental hemostasis-promoting agent comprises oxidized cellulose, oxidized regenerated cellulose, carboxylic oxidized cellulose, carboxylic oxidized regenerated cellulose, thrombin, or tranexamic acid.
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site. A tracking apparatus may be configured to determine a position of a portion of the tissue resection device in three dimensional space.
A61B 10/02 - Instruments for taking cell samples or for biopsy
A61B 18/12 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
A61B 34/20 - Surgical navigation systemsDevices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
G01S 1/00 - Beacons or beacon systems transmitting signals having a characteristic or characteristics capable of being detected by non-directional receivers and defining directions, positions, or position lines fixed relatively to the beacon transmittersReceivers co-operating therewith
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
A device for guiding a barbed suture into a braider preferably includes an elongated body having a proximal end, a distal end, and a longitudinal axis that extends from the proximal end to the distal end of the elongated body. The elongated body includes a first channel extending along the longitudinal axis of the elongated body and having a first distal opening at the distal end of the elongated body, whereby the said first channel has a first cross-sectional area, and a second channel extending along the longitudinal axis of the elongated body and having a second distal opening at the distal end of the elongated body, whereby the second channel has a second cross-sectional area that is different than the first cross-sectional area of the first channel. The device has an elongated slot extending along the longitudinal axis of the elongated body that interconnects the first and second channels. A barbed suture is loaded into the elongated body. The barbed suture includes an elongated core having a proximal end, a distal end, a barbed section including barbs extending outwardly from the elongated core, an end effector secured to the proximal end of the elongated core, and an interconnecting segment of the elongated core that is distal to the end effector and proximal to the barbed section. The barbed section of the barbed suture is disposed within the first channel, the end effector of the barbed suture is disposed within the second channel, and the interconnecting segment of said barbed suture extends through the elongated slot.
A braided barbed suture includes a barbed monofilament insert including an elongated core having a thickness and a plurality of barbs projecting outwardly from opposite sides of the elongated core. The braided barbed suture includes a braided sheath surrounding the elongated core to form a composite core of the braided barbed suture. The composite core has a thickness and the elongated core is located in a center of the composite core. The elongated core thickness is about 6-8 mil and the composite core thickness is about 13-18 mil. A ratio of the elongated core thickness relative to the composite core thickness is between about 0.16 to 0.91. The elongated core has transition zones that form a concave profile. The braided barbed suture has a single breaking point for both the braided sheath and the barbed monofilament insert. The barbed monofilament insert has a PDS monofilament core, and the braided sheath is a VICRYL multifilament yarn braided sheath.
The present invention is directed to an absorbable hemostatic patch that utilizes a biocompatible fibrous, fabric substrate that is melt-blown and napped or loosened at the surface, with the substrate having a low-profile, high flexibility, strength and porosity that is suitable for coating cross-linkable active molecules and ultimately effective for use as a hemostat in situations of problematic bleeding.
A61L 15/60 - Liquid-swellable gel-forming materials, e.g. super-absorbents
A61L 15/64 - Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
75.
TWO COMPONENT SEALING SYSTEMS INCLUDING SYNTHETIC MATRICES AND BIOSYNTHETIC ADHESIVES FOR SEALING RESECTED SURFACES OF ORGANS TO CONTROL BLEEDING, FLUID LEAKS AND AIR LEAKS
A method of sealing a resected surface of an organ includes applying a synthetic matrix to a resected surface of an organ, and applying an adhesive on the synthetic matrix so that the adhesive penetrates through interstices of the synthetic matrix for contacting an interface between the synthetic matrix and the resected surface of the organ. The method includes curing the adhesive for bonding the synthetic matrix to the resected surface of the organ. The synthetic matrix is a non-woven mesh made of polyglactin 910 or any other synthetic or non-synthetic fabric having a similar porosity or density. The adhesive is a biosynthetic or a synthetic adhesive. After penetrating through the pores of the synthetic matrix and curing, the cured biosynthetic or synthetic adhesive mechanically interlocks with the synthetic matrix for adhering the synthetic matrix to the tissue for creating a sealing barrier.
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
Novel compositions and systems for closure of wounds with antimicrobial effectiveness are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2 -5 minutes.
C07F 15/00 - Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
C08F 4/60 - MetalsMetal hydridesMetallo-organic compoundsUse thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths, or actinides together with refractory metals, iron group metals, platinum group metals, manganese, technetium, rhenium, or compounds thereof
78.
SYSTEMS, METHODS AND DEVICES FOR AEROSOL SPRAYING OF SILICONE BASED TOPICAL SKIN ADHESIVES FOR SEALING WOUNDS
An aerosol spray device includes a container having first and second fluid reservoirs disposed therein that are divided from one another. The first fluid reservoir holds a first mixture including a first aerosol propellant and a first part of a silicone based topical skin adhesive that is dissolved in the first aerosol propellant. The second fluid reservoir holds a second mixture including a second aerosol propellant and a second part of the silicone based topical skin adhesive that is dissolved in the second aerosol propellant. An aerosol spray dispensing system is connected with the container, which is configured to combine the first and second mixtures to form the silicone based topical skin adhesive and dispense the silicone based topical skin adhesive from the container as an aerosol spray.
B05C 17/00 - Hand tools or apparatus using hand-held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces
79.
SYSTEMS, DEVICES AND METHODS FOR DISPENSING AND CURING SILICONE BASED TOPICAL SKIN ADHESIVES
A system for dispensing a curable composition includes a dual barrel syringe including a first syringe barrel with a first plunger, and a second syringe barrel with a second plunger. A static mixer is connected with distal ends of the first and second syringe barrels. The first and second plungers are moveable toward the distal ends of the first and second syringe barrels for expelling first and second components of a curable composition from the distal ends of the barrels into the static mixer for mixing the components to form the curable composition. A flexible spreader connected with a distal end of the static mixer has a flat dispensing opening, and a plurality of channels extending to the flat dispensing opening to dispense the curable composition. A hot gas blower generates a hot gas stream flowing distally over the distal end of the flexible spreader for curing the curable composition.
A61B 17/00 - Surgical instruments, devices or methods
A61M 35/00 - Devices for applying media, e.g. remedies, on the human body
B05C 17/005 - Hand tools or apparatus using hand-held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces for discharging material through an outlet orifice by pressure
The present disclosure is directed to a dispenser that includes a receiving opening configured to receive a plurality of medical products into a cavity of the dispenser as an available inventory, wherein each of the plurality of medical products includes an identifier; a plurality of holders in the cavity, each of the plurality of holders configured to store at least one of the plurality of medical products in a fixed location that is associated with the one of the plurality of medical products, and each of the plurality of holders including a dispensing opening; at least two emitters and at least two sensors around a periphery of the receiving opening, wherein the at least two emitters and the at least two sensors are arranged around a periphery of the receiving opening on a plane that is substantially perpendicular to the plurality of dispensing openings; a processor; and a electronic storage device.
G07F 17/00 - Coin-freed apparatus for hiring articlesCoin-freed facilities or services
G07F 9/02 - Devices for alarm or indication, e.g. when emptyAdvertising arrangements in coin-freed apparatus
G07F 11/04 - Coin-freed apparatus for dispensing, or the like, discrete articles from non-movable magazines in which magazines the articles are stored one vertically above the other
G06Q 10/08 - Logistics, e.g. warehousing, loading or distributionInventory or stock management
81.
NOVEL TOPICAL SKIN CLOSURE COMPOSITIONS AND SYSTEMS
Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2 -5 minutes.
A61L 26/00 - Chemical aspects of, or use of materials for, liquid bandages
C08F 4/60 - MetalsMetal hydridesMetallo-organic compoundsUse thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths, or actinides together with refractory metals, iron group metals, platinum group metals, manganese, technetium, rhenium, or compounds thereof
Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2 -5 minutes.
A61L 15/18 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
A61L 15/22 - Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
83.
CONTINUOUS GLYCOLIDE-L-LACTIDE COPOLYMER PRODUCTION PROCESS DEVELOPMENT
The present invention is directed to continuous reaction processes for preparing a glycolide/L-lactide copolymer formulation by continuously introducing glycolide monomer, L-lactide monomer, initiator and optionally a catalyst into at least one continuous reactor vessel under dry nitrogen environment, wherein the monomers, initiator, and optional catalyst are mixed at a first lower temperature and then transferred to a second continuous reactor operating at a second higher temperature, and then exothermally reacting and maintaining at a steady state, the blend of glycolide monomer, lactide monomer, initiator and optional catalyst to produce a PLGA copolymer reaction product.
A method for removing tissues may comprise disposing a tissue resection device at a target tissue site, causing the tissue resection device to resect a core of tissue from the target tissue site, removing the core of tissue from the body, wherein the removing the core of tissue from the body creates a core cavity at the target tissue site.
A spinneret for extruding fibers includes a plate having a proximal surface and a distal surface. The spinneret includes a plurality of holes formed in the plate that extend between the proximal surface and the distal surface of the plate. The holes are spaced from one another, and each hole has a distal end that extends along a central axis. The spinneret has a plurality of contoured entrance zones formed in the proximal surface of the plate, whereby each contoured entrance zone is associated with one of the holes. Each contoured entrance zone extends distally from the proximal surface of the plate to a proximal end of the hole associated therewith. Each contoured entrance zone has substantially no planar or flat surfaces normal to the direction of the central axis of the distal end of the hole associated therewith.
Systems and methods for sealing tissue sites may comprise coring tissue at a target site such that a tissue core is removed from the target site thereby creating a core cavity at the target site and causing sealing of at least a portion of the target site
A61B 17/00 - Surgical instruments, devices or methods
A61B 17/12 - Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
89.
TISSUE RESECTION SYSTEMS AND METHODS FOR DIAGNOSTIC AND THERAPEUTIC IMPLEMENTATION
A method for delivering cancer therapy may comprise introducing a tissue resection device to the tissue site, using the tissue resection device to create a core of tissue, removing at least a portion of the core of tissue from the body to create a tissue cavity, and performing therapeutic management of malignant tissue via the tissue cavity.
A61B 18/18 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
A61B 18/04 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
A61B 18/02 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
A61B 18/20 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
91.
COMPOSITE SUTURE NEEDLES HAVING ELASTICALLY DEFORMABLE SECTIONS
A composite suture needle configured for passing through a smaller cannula used in minimally invasive surgery includes a curved elongated body made of stainless steel. The curved elongated body has a proximal end and a distal end with a pointed tip. The composite suture needle includes a sheath overlying the curved elongated body. The sheath is curved for conforming to the shape of the curved elongated body. The sheath is made of a material that is more elastic than the curved elongated body. The pointed tip of the curved elongated body extends distally beyond the distal end of the sheath. The curved elongated body is made of stainless steel and the sheath is made of a material, such as nitinol, that is more elastic than the elongated body.
An inflatable central distractor is inserted in to a disc space between two vertebral endplates. A perimeter balloon is inserted into the disc space in such a manner as to surround the central inflatable distractor. The perimeter balloon and the central inflatable distractor are simultaneously expanded such that as the central inflatable distractor expands the perimeter balloon surrounds the central inflatable distractor and such that the central inflatable distractor and the perimeter balloon, when expanded, contribute to forcing adjacent vertebral endplates apart.
The present invention is directed to an absorbable hemostatic nonwoven patch that utilizes a biocompatible substrate comprised of melt-blown microfibers as webbed sheets that are layered and bonded/entangled in descending density and ascending porosity; with the substrate having a high flexibility, strength and porosity that is suitable for coating cross-linkable active molecules and ability for laparoscopic use or trocar deployment, ultimately for functional use as a highly effective hemostat in addressing problematic bleeding during both open and minimally invasive surgical procedures.
The present invention is directed to hemostatic sealants having a compressed porous substrate, an electrophilic group containing component that is not gelatin or collagen, a nucleophilic group containing component, and a buffering agent. The present invention also relates to method for manufacture and use of such sealants to seal and/or achieve hemostasis.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
96.
TRANSESOPHAGEAL CATHETER FOR THERMAL PROTECTION OF THE ESOPHAGUS
A system comprising: a fluid supply configured for the delivery of a fluid; a hollow body in fluid-communication with the fluid supply, the hollow body configured to be disposed between a first biological surface and a second biological surface; and a mechanism configured to control delivery of fluid from the fluid supply and through the hollow body to create separation between the first biological surface and the second biological surface.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
97.
FLUID DELIVERY SYSTEM FOR CREATING SEPARATION BETWEEN BIOLOGICAL SURFACES
A system comprising: a fluid supply configured for the delivery of a fluid; a hollow body in fluid-communication with the fluid supply, the hollow body configured to be disposed between a first biological surface and a second biological surface; and a mechanism configured to control delivery of fluid from the fluid supply and through the hollow body to create separation between the first biological surface and the second biological surface.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
98.
PRECISION PLANNING, GUIDANCE AND PLACEMENT OF PROBES WITHIN A BODY
A method for navigating a probe to a location within a body of a patient, the method comprising visualizing a three-dimensional image of a region of a body of a patient; receiving a selection of a target location within said three-dimensional image of a region of a patient's body; determining and visualizing a preferred pathway for the probe to follow from an external entry point on the patient's body to the target location; visualizing the preferred pathway for the probe simultaneously with an indication of the current actual position of the probe in real time such that the simultaneous visualizations enables a user to align the current actual position of the probe with the preferred pathway; and updating and visualizing an indication of the current actual position of the probe in real time as the probe is advanced to the target location.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
99.
SPRAY DEVICES HAVING SIDE-BY-SIDE SPRAY TIPS FOR DISPENSING TWO FLUIDS THAT CHEMICALLY REACT TOGETHER
A spray device includes a first spray tip having a first fluid pathway defining a first flow area, and a second spray tip includes a second fluid pathway that defines a second flow area that is larger than the first flow area of the first spray tip. The first and second spray tips are side-by-side and spaced from one another at a distal end of the spray device. When a first fluid having a volumetric flow rate is introduced into the first spray tip and a second fluid having the same volumetric flow rate is introduced into the second spray tip, the first fluid will flow through the first fluid pathway at a greater velocity than the second fluid will flow through the second fluid pathway.
A61B 17/00 - Surgical instruments, devices or methods
B05B 1/34 - Nozzles, spray heads or other outlets, with or without auxiliary devices such as valves, heating means designed to influence the nature of flow of the liquid or other fluent material, e.g. to produce swirl
B05B 7/10 - Spray pistolsApparatus for discharge producing a swirling discharge
100.
DISPENSING SYSTEMS AND DEVICES HAVING ANTI-CLOGGING SPRAY TIPS FOR DISPENSING TWO OR MORE FLUIDS THAT REACT TOGETHER
A spray tip for dispensing fluids that react together includes a first lumen for a first fluid, a second lumen for a second fluid, and a dispensing cap located at distal ends of the respective first and second lumens and defining a distal end of the spray tip. The dispensing cap includes a distal end wall defining a closed end of the dispensing cap, a first spray opening formed in the distal end wall that is in fluid communication with the first lumen, a second spray opening formed in the distal end wall that is in fluid communication with the second lumen, and an external dividing wall that projects distally from the distal end wall of the dispensing cap and that extends between the first and second spray opening for forming a barrier between the first and second spray openings.
patents
